Add Your Voice to NANOBEAT:
Expression of Interest for the Patient Advisory Board

Zoom Background

Who can apply?

We welcome Expressions of Interest from people who can bring a patient or lived-experience perspective to the NANOBEAT project, including:

  • People living with atrial fibrillation (AF) or other heart rhythm conditions
  • People with conduction disorders, including left bundle branch block (LBBB)
  • Family members or caregivers supporting someone with a heart rhythm condition
  • Patient advocates or representatives from patient organisations
  • Individuals from diverse backgrounds and countries, to reflect a wide range of experiences

You do not need scientific or medical training to apply. What matters most is your lived experience, your willingness to share your perspective, and an interest in helping researchers understand what is important to patients.

What is the NANOBEAT project?

NANOBEAT is a European research effort aiming to develop a completely new way to help people whose hearts don’t conduct electrical signals properly, such as in atrial fibrillation (AF) and bundle branch blocks, conditions that affect how the heart beats and can lead to symptoms like palpitations, fatigue, dizziness, heart failure, stroke and reduced quality of life.

Why is this important?

  • Problems with electrical conduction in the heart (how the heart’s electrical signals travel) are common and can have serious health consequences.
  • Current treatments (like medications or ablation procedures) help many people but aren’t always effective and sometimes have limitations.

What is NANOBEAT trying to do?

The project is working to create a new medical technology, a special conductive material that could be inserted into the heart using a minimally invasive procedure (a catheter). This material is designed to:

  • Help restore electrical signals in parts of the heart where conduction is impaired.
  • Potentially improve how the heart beats, without major surgery.
  • Lay the groundwork for future human trials of this technology.

In simple terms: the goal is to fix the wiring of the heart in a way that current therapies do not. Instead of just managing symptoms, this approach aims to repair the problem at its source.

Who is involved?

The project brings together scientists and engineers from several European research centres and companies, including academic hospitals and medical technology partners.

What is the long-term goal?

  • Developing the new technology (called CardioINK) so it can be made available to patients in the future.
  • Planning how it could be introduced safely to healthcare systems in Europe and the United States.
  • Including patients’ perspectives to make sure the research reflects real needs and priorities of the people it aims to help

Have your say and complete the Expression of Interest for the Patient Advisory Board application form.

 

Apply Now